Puma Biotechnology to present its abstract at ESMO 2017
Puma Biotechnology, Inc., a biopharmaceutical company announces the release of two abstracts on its drug neratinib. It will be presented at the European Society for Medical Oncology (ESMO) 2017 Congress, which is to be held from September 8 – 12 in Madrid, Spain.
Reference Link: http://markets.businessinsider.com/news/stocks/puma-biotechnology-announces-publication-of-abstracts-for-esmo-2017-1002296389
Leave a Reply
You must be logged in to post a comment.